In this episode of Research Forward, we sit down with Tommy Jackson, CEO of Prelude, to explore how technology is transforming clinical research. Tommy shares his journey from finance and Silicon Valley startups to leading one of the most trusted eClinical platforms in animal health—and now expanding into human health trials. We discuss:

• How Prelude’s Electronic Data Capture (EDC) system accelerates trial timelines by up to 50% and reduces database build times by 75%.
• Lessons human health research can learn from decades of optimization in veterinary trials.
• Why user-friendly design and integrated modules like ePRO and eConsent are critical for trial success.
• The role of robust customer success teams in overcoming resistance to digital adoption.
• How modern EDC systems support compliance, improve data quality, and even help advance the “Three Rs” in animal research.

If you’ve ever wondered how clinical data management can evolve to be faster, more accurate, and more humane, this conversation is for you.

In this episode of the Research Forward Podcast, host David Mayo welcomes Dr. Michael Florea, co-founder and CEO of Olden Labs, a Harvard-trained synthetic biologist revolutionizing longevity research. Michael shares his journey from teenage lab work in Estonia to developing whole-body gene delivery systems at Harvard Medical School, and ultimately founding Olden Labs to tackle the bottlenecks of animal studies. Discover how Olden Labs is building the world’s first automated animal research lab using AI-powered smart cages and robotics to transform data collection, reduce costs, and improve animal welfare. From non-invasive health monitoring to accelerating disease model development, this conversation explores the intersection of engineering, biology, and artificial intelligence in modern biotech. Learn how automation is reshaping reproducibility, ethical standards, and the future of preclinical research—one smart cage at a time.

In this episode of the Research Forward Podcast, host David sits down with Arantza Muriana, Chief Investigational Officer and CEO of Biobide’s American affiliate. Arantza shares her inspiring journey from clinical trials in Spain to pioneering preclinical research using zebrafish and other aquatic models. Together, they explore how Biobide is transforming drug discovery, toxicology, and environmental safety testing through innovative, ethical, and high-throughput methods.

Learn how zebrafish are helping reduce animal testing, accelerate rare disease research, and improve regulatory science. From AI-driven image analysis to personalized medicine and environmental impact assessments, this conversation dives deep into the science, challenges, and promise of alternative models in modern biotech.